Rare diseases
Investigational molecules
Locations
Study of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer
PolandStudy Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema
PolandStudy of nivolumab, relatlimab and bevacizumab combination for patients with untreated advanced or metastatic liver cancer (hepatocellular carcinoma)
PolandStudy on the Effects of SAR443820 and Gadobutrol in Patients with Multiple Sclerosis
PolandStudy on the Safety, Effectiveness, and Blood Movement of Bimekizumab in Adolescents with Moderate to Severe Plaque Psoriasis
PolandStudy on the Safety and Effectiveness of Cenobamate for Children with Focal Seizures
PolandStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations
PolandStudy on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy
PolandStudy of Pembrolizumab, Olaparib, and Pemetrexed for Patients with Stage IV Non-Small Cell Lung Cancer
PolandStudy on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
PolandStudy on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
PolandStudy on the Safety and Effectiveness of ADX-914 for Patients with Moderate to Severe Atopic Dermatitis
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
